These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22994082)

  • 1. [Optimization of cell therapy in patients with inflammatory bowel diseases].
    Lazebnik LB; Knyazev OV; Parfenov AI; Ruchkina IN; Shcherbakov PL; Khomeriki SG; Konoplyannikov AG
    Ter Arkh; 2012; 84(8):10-7. PubMed ID: 22994082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune response to biological therapy of inflammatory bowel diseases].
    Kniazev OV; Parfenov AI; Ruchkina IN; Lazebnik LB; Sagynbaeva VÉ
    Ter Arkh; 2013; 85(12):55-9. PubMed ID: 24640669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases].
    Lazebnik LB; Konopliannikov AG; Kniazev OV; Parfenov AI; Tsaregorodtseva TM; Ruchkina IN; Khomeriki SG; Rogozina VA; Konopliannikova OA
    Ter Arkh; 2010; 82(2):38-43. PubMed ID: 20387674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation].
    Lazebnik LB; Kniazev OV; Konopliannikov AG; Parfenov AI; Ruchkina IN; Mikhaĭlova ZF; Tsaregorodtseva TM; Khomeriki SG; Rogozina VA; Gudkova RB; Shcherbakov PL; Konopliannikova OA
    Eksp Klin Gastroenterol; 2010; (11):3-15. PubMed ID: 21485508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis.
    D'Haens G; Sandborn WJ; Barrett K; Hodgson I; Streck P
    Am J Gastroenterol; 2012 Jul; 107(7):1064-77. PubMed ID: 22565161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Andoh A; Tsujikawa T; Fujiyama Y; Mitsuyama K; Sata M; Yamada M; Iwaoka Y; Kanke K; Hiraishi H; Hirayama K; Arai H; Yoshii S; Uchijima M; Nagata T; Koide Y
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsule-endoscopic findings of ulcerative colitis patients.
    Higurashi T; Endo H; Yoneda M; Hosono K; Sakai E; Takahashi H; Inamori M; Uchiyama S; Kojima T; Kawana K; Natsumeda Y; Nagase H; Nakajima A
    Digestion; 2011; 84(4):306-14. PubMed ID: 22041924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A; Gasiorowska A; Małecka-Panas E
    Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol.
    Prantera C; Kohn A; Campieri M; Caprilli R; Cottone M; Pallone F; Savarino V; Sturniolo GC; Vecchi M; Ardia A; Bellinvia S
    Aliment Pharmacol Ther; 2009 Nov; 30(9):908-18. PubMed ID: 19678813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis.
    Chojnacki C; Wisniewska-Jarosinska M; Walecka-Kapica E; Klupinska G; Jaworek J; Chojnacki J
    J Physiol Pharmacol; 2011 Jun; 62(3):327-34. PubMed ID: 21893693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.
    Sandborn WJ; Korzenik J; Lashner B; Leighton JA; Mahadevan U; Marion JF; Safdi M; Sninsky CA; Patel RM; Friedenberg KA; Dunnmon P; Ramsey D; Kane S
    Gastroenterology; 2010 Apr; 138(4):1286-96, 1296.e1-3. PubMed ID: 20064514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammatory bowel diseases in the XXI century].
    Parfenov AI
    Eksp Klin Gastroenterol; 2012; (3):3-6. PubMed ID: 22830219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transplantation of allogeneic mesenchymal stem cells from the bone marrow increases duration of remission and reduces the risk of ulcerative colitis relapse].
    Lazebnik LB; Kniazev OV; Parfenov AI; Ruchkina IN; Rogozina VA; Konopliannikov AG
    Eksp Klin Gastroenterol; 2010; (3):5-10. PubMed ID: 20496783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
    Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
    Cohen RD; Woseth DM; Thisted RA; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis.
    Zeisler B; Lerer T; Markowitz J; Mack D; Griffiths A; Bousvaros A; Keljo D; Rosh J; Evans J; Kappelman M; Otley A; Kay M; Grossman A; Saeed S; Carvalho R; Oliva-Hemker M; Faubion W; Sudel B; Pfefferkorn M; Ashai-Khan F; Leleiko N; Hyams J;
    J Pediatr Gastroenterol Nutr; 2013 Jan; 56(1):12-8. PubMed ID: 22847466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of inflammatory bowel disease.
    Botoman VA; Bonner GF; Botoman DA
    Am Fam Physician; 1998 Jan; 57(1):57-68, 71-2. PubMed ID: 9447214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of clinical patterns in ulcerative colitis: a long-term follow-up.
    Bresci G; Parisi G; Gambardella L; Banti S; Bertoni M; Rindi G; Capria A
    Int J Clin Pharmacol Res; 1997; 17(1):17-22. PubMed ID: 9403349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: a meta-analysis.
    Tong JL; Huang ML; Xu XT; Qiao YQ; Ran ZH
    J Dig Dis; 2012 Apr; 13(4):200-7. PubMed ID: 22435504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.